• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

SeqLL Defers Proposed Cash and Stock Distributions to Stockholders in Connection With Proposed Acquisition

Share:

November 7, 2023

SeqLL Inc. (Nasdaq: SQL, SQLLW) has withdrawn its previously considered cash and stock dividends linked to acquiring Lyneer Investments LLC and revamping operations. Despite a set record date of September 26, 2023, dividend specifics were undecided. Challenges endangering the Lyneer deal prompted the reversal. SeqLL will propose a compensation plan to its shareholders post-acquisition, offering the equivalent value they’d have obtained with the canceled dividends.

SeqLL Inc. (“SeqLL” or the “Company”) (Nasdaq: SQL, SQLLW), today announced the decision of its Board of Directors to cancel the special cash dividend and stock dividend that it intended to make to its common stockholders in connection with, and subject to, the consummation of its planned acquisition of Lyneer Investments LLC (“Lyneer”) and the disposition of its current business operations. The Company had previously set September 26, 2023, as the record date for the dividends (the “Record Date”). While the Record Date had been set, the dividends had not yet been declared by the Board nor had the amount of the proposed dividends been set. The cancellation was due to significant logistical issues associated with the proposed dividends that the Board believed could have jeopardized the ability of the Company to complete its planned acquisition. In lieu of making the cash dividend and the stock dividend, the Company expects to make a settlement offer to all of its stockholders as of the Record Date within 90 days of the consummation of its acquisition of Lyneer to settle any claims for failing to pay such dividends by issuing to such stockholders the amount of cash and the number of shares of its common stock that such stockholders would have received had such dividends been declared and made.

Source: Biospace

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • AI In The Clinic: What AI Will Look Like For HealthcareAI In The Clinic: What AI Will Look Like For Healthcare
  • RefleXion Medical Raises $125M for Biology-Guided RadiotherapyRefleXion Medical Raises $125M for Biology-Guided Radiotherapy
  • Patient Co-creation is a Tall, But Worthwhile, Order for Health InnovatorsPatient Co-creation is a Tall, But Worthwhile, Order for Health Innovators
  • Argon Medical Devices Acquires Mana-Tech, Ltd.Argon Medical Devices Acquires Mana-Tech, Ltd.
  • ADVANZ PHARMA Corp. Limited Announces Agreement Of Terms To Be Acquired By Nordic CapitalADVANZ PHARMA Corp. Limited Announces Agreement Of Terms To Be Acquired By Nordic Capital
  • Fujifilm & Volpara Partner to Help Clinicians Determine Patient Breast DensityFujifilm & Volpara Partner to Help Clinicians Determine Patient Breast Density
  • Medable & Pluto Health Partner to Increase Patient Access to Clinical TrialsMedable & Pluto Health Partner to Increase Patient Access to Clinical Trials
  • 83% of Consumers Would Feel Safer in Hospitals with COVID-19 Contact Tracing Technology, Survey Reveals83% of Consumers Would Feel Safer in Hospitals with COVID-19 Contact Tracing Technology, Survey Reveals

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications